HU-336
 | |
| Systematic (IUPAC) name | |
|---|---|
|
(6aR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,10,10a-tetrahydro-1H-benzo[c]chromene-1,4(6H)-dione | |
| Identifiers | |
| PubChem | CID 11370880 |
| ChemSpider |
9545797  |
| Chemical data | |
| Formula | C21H28O3 |
| Molar mass | 328.445 g/mol |
| |
| |
| (verify) | |
HU-336 is a strongly antiangiogenic compound, significantly inhibiting angiogenesis at concentrations as low as 300nM. It inhibits angiogenesis by directly inducing apoptosis of vascular endothelial cells without changing the expression of pro- and antiangiogenic cytokines and their receptors. HU-336 is highly effective against tumor xenografts in nude mice.[1]
See also
References
- ↑ Natalya M. Kogan; et al. (2006). "A Cannabinoid Quinone Inhibits Angiogenesis by Targeting Vascular Endothelial Cells". Molecular Pharmacology 70 (1): 51–59. doi:10.1124/mol.105.021089. PMID 16571653.
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.